Oncology Pharma Inc. (OTCMKTS:ONPH – Get Free Report) reached a new 52-week low during trading on Friday . The company traded as low as $0.0001 and last traded at $19.29, with a volume of 318 shares. The stock had previously closed at $0.0003.
Oncology Pharma Stock Performance
Oncology Pharma Company Profile
Oncology Pharma Inc, an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc and changed its name to Oncology Pharma Inc in June 2019.
Featured Articles
- Five stocks we like better than Oncology Pharma
- What Is WallStreetBets and What Stocks Are They Targeting?
- LightPath Stock Eyes 50% Upside on Defense Demand Surge
- How to start investing in penny stocks
- CRWD Stock Hits Key Inflection Point Ahead of Earnings
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rigetti’s Q3 Miss Reveals Quantum Funding and Timing Pressures
Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
